Anti-Asthmatic Activity of Salbutamol and Theophylline Anhydrous on Goat Trachea

Asthma is a prevalent respiratory disorder characterized by airway inflammation and bronchoconstriction, significantly impacting patients’ quality of life. This review investigates the anti-asthmatic activities of salbutamol, a selective β2-adrenergic agonist, and theophylline anhydrous, a phosphodiesterase inhibitor, using goat trachea as a model system. Goat tracheal tissues exhibit physiological similarities to human airways, making them suitable for studying bronchial responses.Salbutamol demonstrates rapid bronchodilation by relaxing bronchial smooth muscle through β2 receptor stimulation. In contrast, theophylline enhances cAMP levels, leading to prolonged bronchial relaxation. Experimental results indicate that both agents effectively induce relaxation of pre-contracted tracheal tissues, with salbutamol acting more swiftly and theophylline offering sustained effects. This review highlights their distinct mechanisms, comparative efficacy, and safety profiles, underscoring their relevance in asthma management. Further research is warranted to explore combination therapies and novel drug formulations to optimize treatment strategies for asthma. Asthma is a chronic respiratory condition that affects millions worldwide, leading to significant morbidity and impaired quality of life. The management of asthma typically involves bronchodilators, with salbutamol and theophylline anhydrous being two of the most widely used agents. Salbutamol, a selective β2-adrenergic agonist, provides rapid relief from bronchoconstriction by relaxing bronchial smooth muscle. Theophylline anhydrous, on the other hand, acts as a phosphodiesterase inhibitor, increasing intracellular cAMP levels and promoting sustained bronchodilation.This review critically examines the anti-asthmatic activities of salbutamol and theophylline through studies conducted on goat trachea, a model that closely mimics human airway physiology. In vitro experiments demonstrate that salbutamol induces immediate and significant relaxation of pre-contracted tracheal tissues, making it particularly effective for acute asthma attacks. In contrast, theophylline’s bronchodilator effects, while slower to onset, are longer-lasting, offering benefits for chronic asthma management. Both agents are generally well-tolerated, although theophylline requires careful monitoring due to potential toxicity at higher concentrations. This review underscores the importance of understanding the distinct pharmacological profiles of these drugs, their comparative efficacy, and safety considerations in clinical practice. Additionally, it highlights the need for further research on combination therapies and novel drug formulations that could enhance treatment efficacy and minimize side effects for patients with asthma. Ultimately, insights gained from studies on goat trachea can inform therapeutic strategies and improve outcomes for individuals suffering from this pervasive respiratory condition.